+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 45Years
FEMALE
ID07802561

Comparing Metformin and Glyburide for Managing Blood Sugar in Pregnant Women with Gestational Diabetes

Led by Nishtar Medical University · Updated on 2026-09-03

92

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two oral medications, metformin and glyburide, to manage blood sugar levels in pregnant women diagnosed with gestational diabetes mellitus GDM who need medication treatment. The study aims to find out whether treatment failure is less common with metformin or glyburide. Treatment failure means that blood sugar levels are not adequately controlled after up to four weeks of treatment. Participants will be randomly assigned to receive either metformin or glyburide. Metformin starts at 850 mg once daily and can be increased up to 2,550 mg per day based on blood sugar levels. Glyburide starts at 2.5 mg twice daily and can be increased up to 20 mg per day. Treatment continues until delivery. Blood sugar is monitored regularly using a glucometer, and if treatment fails or side effects occur, participants may be switched to insulin therapy. During pregnancy and until delivery, participants will have their blood sugar control tracked and maternal outcomes such as preeclampsia, polyhydramnios, and preterm delivery will be recorded. The study also monitors newborn outcomes including birth weight and NICU admission. The main outcome measured is treatment failure within four weeks of starting oral treatment, helping determine which medication better controls blood sugar in this population.

CONDITIONS

Brief Title

Comparison of Metformin Versus Glyburide for Blood Sugar Control in Women With Gestational Diabetes

Research Team

I

Iqra M Principal Investigator, MBBS

S

Saima A Professor, FCPS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here